MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

GenMark Diagnostics Company Profile (NASDAQ:GNMK)

Consensus Ratings for GenMark Diagnostics (NASDAQ:GNMK) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $8.96 (2.97% upside)

Analysts' Ratings History for GenMark Diagnostics (NASDAQ:GNMK)
Show:
DateFirmActionRatingPrice TargetActions
6/17/2016Needham & Company LLCInitiated CoverageBuy$11.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Raymond JamesLower Price TargetOutperform$9.00 -> $7.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Cowen and CompanyLower Price Target$7.25 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016JPMorgan Chase & Co.Lower Price TargetOverweight$15.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for GenMark Diagnostics (NASDAQ:GNMK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/3/2016Q116($0.29)($0.30)$10.67 million$11.06 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415($0.27)($0.21)$12.34 million$13.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315($0.31)($0.27)$8.24 million$8.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.31)($0.29)$7.59 million$7.65 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.24)($0.24)$10.10 million$10.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.28)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.32)($0.23)$5.80 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.29)($0.27)$4.79 million$6.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114($0.25)($0.21)$6.40 million$7.91 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q413($0.22)($0.21)$6.06 million$6.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313($0.27)($0.24)$4.60 million$4.64 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.26)($0.25)$5.05 million$5.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013($0.17)($0.13)$9.53 million$11.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2011($0.32)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2011($0.45)($0.39)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.49)($0.56)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2011($0.52)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for GenMark Diagnostics (NASDAQ:GNMK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for GenMark Diagnostics (NASDAQ:GNMK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for GenMark Diagnostics (NASDAQ:GNMK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/7/2016Hany MassaranyCEOSell1,188$8.98$10,668.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Michael GleesonSVPSell868$8.80$7,638.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Ingo ChakravartySVPSell184$8.53$1,569.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Ingo ChakravartySVPSell582$5.42$3,154.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Eric StierSVPSell363$5.79$2,101.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Hany MassaranyCEOSell1,160$5.79$6,716.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Michael KagnoffDirectorBuy2,500$4.90$12,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Hany MassaranyCEOSell1,193$5.76$6,871.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Michael GleesonSVPSell559$5.76$3,219.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Eric StierSVPSell365$4.87$1,777.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Ingo ChakravartySVPSell697$5.04$3,512.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Hany MassaranyCEOSell9,173$4.99$45,773.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Michael GleesonSVPSell3,083$4.99$15,384.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2016Hany MassaranyCEOSell648$6.80$4,406.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2016Michael GleesonSVPSell227$6.80$1,543.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Eric StierSVPSell240$7.26$1,742.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Hany MassaranyCEOSell1,735$7.26$12,596.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Hany MassaranyCEOSell3,571$7.71$27,532.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Michael GleesonSVPSell1,664$7.62$12,679.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Lisa M GilesDirectorBuy4,000$6.60$26,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Michael KagnoffDirectorBuy5,000$6.70$33,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Scott MendelCFOBuy10,000$6.47$64,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Daryl FaulknerDirectorBuy4,000$7.33$29,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Jennifer Anne WilliamsSVPSell14,245$9.98$142,165.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Jennifer Anne WilliamsSVPSell9,245$10.00$92,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Hany MassaranyCEOSell1,683$9.64$16,224.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Jennifer Anne WilliamsSVPSell18,280$9.99$182,617.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2015Jennifer Anne WilliamsSVPSell1,867$9.59$17,904.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Hany MassaranyCEOSell3,865$9.62$37,181.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Scott MendelCFOBuy10,000$9.10$91,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Hany MassaranyCEOSell1,698$9.12$15,485.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Michael GleesonSVPSell1,595$9.55$15,232.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Hany MassaranyCEOSell3,486$9.47$33,012.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Hany MassaranyCEOSell5,942$11.52$68,451.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Jennifer Anne WilliamsSVPSell30,000$12.56$376,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Hany MassaranyCEOSell28,110$11.88$333,946.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Jeffrey Alan HawkinsSVPSell6,832$12.01$82,052.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Jennifer Anne WilliamsSVPSell722$11.83$8,541.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Michael KagnoffDirectorBuy5,000$11.84$59,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Ingo ChakravartySVPSell3,310$12.06$39,918.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2015Hany MassaranyCEOSell5,982$12.88$77,048.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015Hany MassaranyCEOSell4,858$13.00$63,154.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Kevin C OboyleDirectorSell291$12.40$3,608.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Eric StierSVPSell235$12.51$2,939.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Hany MassaranyCEOSell1,700$12.51$21,267.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Hany MassaranyCEOSell3,300$12.06$39,798.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Jeffrey Alan HawkinsSVPSell1,350$12.06$16,281.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Jon Faiz KayyemSVPSell6,000$11.01$66,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014Hany MassaranyCEOSell5,804$9.00$52,236.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2014Michael GleesonSVPSell55$9.10$500.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Hany MassaranyCEOSell1,678$9.86$16,545.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Hany MassaranyCEOSell3,795$10.04$38,101.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Michael GleesonSVPSell1,833$10.04$18,403.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Michael GleesonSVPSell52$11.15$579.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Jon Faiz KayyemSVPSell6,000$13.60$81,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Hany MassaranyCEOSell1,115$11.64$12,978.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Jon Faiz KayyemSVPSell1,483$10.69$15,853.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Hany MassaranyCEOSell2,700$10.67$28,809.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Kevin C OboyleDirectorSell1,603$10.98$17,600.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2014Jon Faiz KayyemSVPSell6,000$11.06$66,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Richard SlanskyCFOSell2,302$9.26$21,316.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Hany MassaranyCEOSell3,985$9.87$39,331.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2014Jennifer Anne WilliamsSVPSell30,195$9.97$301,044.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014Jon Faiz KayyemSVPSell7,355$12.46$91,643.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Jon Faiz KayyemSVPSell50,000$14.05$702,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Hany MassaranyCEOSell4,698$13.31$62,530.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Michael GleesonSVPSell2,211$11.14$24,630.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Hany MassaranyCEOSell3,968$11.14$44,203.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2013Hany MassaranyCEOSell3,925$12.05$47,296.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Jon Faiz KayyemSVPSell6,000$12.14$72,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Jeffrey Alan HawkinsSVPSell1,890$11.60$21,924.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Hany MassaranyCEOSell2,354$11.60$27,306.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Jon Faiz KayyemSVPSell1,545$11.60$17,922.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Jon Faiz KayyemSVPSell1,310$10.15$13,296.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Jon Faiz KayyemSVPSell6,000$10.40$62,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for GenMark Diagnostics (NASDAQ:GNMK)
DateHeadline
06/30/16 07:05 AMShare Update and Earnings Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph
06/30/16 07:05 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Company Rating and Target Watch - Telanagana Press
06/28/16 09:04 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 04:08 PMBroker Outlook For The Week Ahead GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
06/27/16 08:41 AMWill GenMark Diagnostics, Inc. (NASDAQ:GNMK) Surprise This Quarter? - Investor Newswire
06/25/16 08:06 AMStrong Sell Calls Recommendations For GenMark Diagnostics, Inc. (NASDAQ:GNMK) At 0 - Investor Newswire
06/24/16 04:19 PMGenMark Diagnostics, Inc. (GNMK) Updated Price Targets - FTSE News
06/22/16 04:23 PMRecently Issued Stock Ratings For GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
06/21/16 08:52 AMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Yearly Sales Projections At $66.845 - Investor Newswire
06/19/16 08:32 AMStrong Buy Calls Count For GenMark Diagnostics, Inc. (NASDAQ:GNMK) At 3 - Investor Newswire
06/17/16 04:09 AMGenMark Diagnostics Inc. (GNMK) Drops 5.31% on June 15 - Equities.com
06/15/16 04:18 PMBrokers Issue Average Price Target Of 12.07 On GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard
06/09/16 04:24 PMGenMark Diagnostics, Inc. (NasdaqGM:GNMK) Fundamental Star Rating Report - CML News
06/08/16 03:38 PMGenMark Achieves CE Mark for its ePlex® Sample-to-Answer System - [at noodls] - e87991c1-5e4b-4dea-9180-152f3152928b.pdf June 8, 2016 European Customer Agreements in Place for Initial Systems CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider ...
06/08/16 03:06 PMGENMARK DIAGNOSTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Fi -
06/06/16 04:07 PMGENMARK DIAGNOSTICS INC. (NASDAQ:GNMK) Financial Condition Compared to S&P 500 - CML News
06/06/16 03:38 PMGenMark Diagnostics to Present at the William Blair 36th Annual Growth Stock Conference - [at noodls] - d6d04700-a86c-4b90-95db-56b795cc2be0.pdf June 6, 2016 CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing ...
06/06/16 07:43 AMAre Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) After Last Week? - HNN
06/04/16 09:40 PMNeedham & Company LLC Reiterates “Buy” Rating for GenMark Diagnostics, Inc (GNMK) - Let Me Know About This
06/04/16 04:16 PMEarnings Surprise in Focus: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Investor Newswire
06/03/16 02:22 PMETF’s with exposure to GenMark Diagnostics, Inc. : June 3, 2016 -
06/03/16 04:55 AMGenMark Diagnostics Inc. (GNMK) is Trading Higher on Unusual Volume for June 01 - Equities.com - GenMark Diagnostics Inc. (GNMK) is Trading Higher on Unusual Volume for June 01Equities.comGenMark Diagnostics Inc. (GNMK) experienced unusually high volume on Jun. 01, as the stock gained 8.63% to a closing price of $8.18. The stock saw 385,768 shares trade hands over the course of the day on 2,671 trades. Given that the stock's average ...
06/02/16 04:28 PMGenmark Diagnostics Incorporated (NASDAQ:GNMK) Sellers Covered 2.09% of Their Shorts - HNN - Genmark Diagnostics Incorporated (NASDAQ:GNMK) Sellers Covered 2.09% of Their ShortsHNNThe short interest to Genmark Diagnostics Incorporated's float is 12.62%. The stock is up 3.42% or $0.28 after the news, hitting $8.46 per share. About 175,954 shares traded hands. GenMark Diagnostics, Inc (NASDAQ:GNMK) has risen 21.36% since October ...
06/01/16 04:35 PMStock Review and Earnings Check on GenMark Diagnostics, Inc. (NASDAQ:GNMK) - HNN - Stock Review and Earnings Check on GenMark Diagnostics, Inc. (NASDAQ:GNMK)HNNCurrently, sell-side analysts are expecting GenMark Diagnostics, Inc. (NASDAQ:GNMK) to report quarterly EPS of $-0.34. The company's next earnings report is expected to be published on or around 2016-08-04 for the period ending on 2016-06-30.and more »
06/01/16 04:35 PMGenMark Diagnostics Inc. (GNMK) Jumps 8.63% on June 01 - Equities.com - GenMark Diagnostics Inc. (GNMK) Jumps 8.63% on June 01Equities.comGenMark Diagnostics Inc. (GNMK) was among the biggest gainers on the Russell 2000 for Wednesday June 01 as the stock popped 8.63% to $8.18, representing a gain of $0.65 per share. Some 385,768 shares traded hands on 2,671 trades, compared with ...GenMark Diagnostics, Inc (NASDAQ:GNMK)'s Company Shares Increased 28.94% After High VolatilityFranklin IndependentGenMark Diagnostics, Inc (GNMK) Given Buy Rating at Canaccord GenuityLet Me Know About ThisNew Analyst Ratings On GenMark Diagnostics, Inc. (GNMK)Risers & Fallersall 4 news articles »
06/01/16 04:38 AMGenMark Diagnostics, Inc (GNMK) Given Buy Rating at Canaccord Genuity - Let Me Know About This - GenMark Diagnostics, Inc (GNMK) Given Buy Rating at Canaccord GenuityLet Me Know About ThisGenMark Diagnostics logo GenMark Diagnostics, Inc (NASDAQ:GNMK)'s stock had its “buy” rating reiterated by stock analysts at Canaccord Genuity in a report issued on Wednesday. They presently have a $8.00 price target on the stock. Canaccord Genuity's ...New Analyst Ratings On GenMark Diagnostics, Inc. (GNMK)Risers & FallersStock Review and Earnings Check on GenMark Diagnostics, Inc. (NASDAQ:GNMK)HNNall 3 news articles »
05/31/16 03:51 PMGENMARK DIAGNOSTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/31/16 08:53 AMNext Weeks Broker Price Targets For GenMark Diagnostics, Inc. (GNMK) - Share Trading News - Next Weeks Broker Price Targets For GenMark Diagnostics, Inc. (GNMK)Share Trading NewsGenMark Diagnostics, Inc. has a 50 day moving average of 5.90 and a 200 day moving average of 6.19. The stock's market capitalization is 313.21M, it has a 52-week low of 4.20 and a 52-week high of 10.84. The share price of the company (GNMK) was up ...Are Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) After Last Week?The Postall 2 news articles »
05/23/16 12:18 PMAre Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) After Last Week? - Wall Street Hints and News - Are Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) After Last Week?Wall Street Hints and NewsOut of 7 analysts covering Genmark Diagnostics (NASDAQ:GNMK), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Genmark Diagnostics has been the topic of 4 analyst reports since October 14, 2015 according to StockzIntelligence Inc.GenMark Diagnostics, Inc. (GNMK) Broker Price Targets For The Coming WeekShare Trading Newsall 2 news articles »
05/23/16 12:18 PMStock Rating Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Wall Street Hints and News - Stock Rating Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.6 on shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK). Covering ...and more »
05/21/16 06:32 PMGenMark Diagnostics Inc. (GNMK) Jumps 8.97% on May 20 - Equities.com - GenMark Diagnostics Inc. (GNMK) Jumps 8.97% on May 20Equities.comGenMark Diagnostics Inc. (GNMK) was among the biggest gainers on the Russell 2000 for Friday May 20 as the stock popped 8.97% to $6.56, representing a gain of $0.54 per share. Some 228,155 shares traded hands on 1,799 trades, compared with an ...and more »
05/19/16 12:11 AMShare Recap and Earnings Focus on GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Wall Street Hints and News - Share Recap and Earnings Focus on GenMark Diagnostics, Inc. (NASDAQ:GNMK)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating GenMark Diagnostics, Inc.and more »
05/18/16 07:01 PMRevenue Update on GenMark Diagnostics Inc(NASDAQ:GNMK) - Trade Calls - Revenue Update on GenMark Diagnostics Inc(NASDAQ:GNMK)Trade CallsGenMark Diagnostics Inc(NASDAQ:GNMK) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 3, 2016. Company reported revenue of $11.06M. Analysts estimated a revenue of $10.67M. Earnings per ...GenMark Diagnostics, Inc (NASDAQ:GNMK)'s Company Shares Decreased 3.19% After High VolatilityFranklin IndependentRecently Changed Price Targets On GenMark Diagnostics, Inc. (GNMK)Risers & FallersShare Recap and Earnings Focus on GenMark Diagnostics, Inc. (NASDAQ:GNMK)Wall Street Hints and Newsall 4 news articles »
05/17/16 11:12 AMConsensus Rating Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Wall Street Hints and News - Consensus Rating Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK)Wall Street Hints and NewsEquity research analysts currently have a consensus rating of 1.6 on shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy ...and more »
05/12/16 07:45 PMShort Interest In GenMark Diagnostics Decreases By 11.2% - The most recent short interest data has been released for the 04/29/2016 settlement date, which shows a 558,337 share decrease in total short interest for GenMark Diagnostics, Inc. (GNMK), to 4,404,251, a decrease of 11.25% since 04/15/2016. Total short ...
05/10/16 07:29 PMCheck on Analyst Ratings GenMark Diagnostics, Inc. (NASDAQ:GNMK) - B.O.D.Y Confidential - Check on Analyst Ratings GenMark Diagnostics, Inc. (NASDAQ:GNMK)B.O.D.Y ConfidentialCovering Wall Street analysts have an average rating of 1.5 on shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating falls on a 1 to 5 ...and more »
05/10/16 07:28 PMPerformance Recap and Target Perspective on GenMark Diagnostics, Inc. (NASDAQ:GNMK) - B.O.D.Y Confidential - Performance Recap and Target Perspective on GenMark Diagnostics, Inc. (NASDAQ:GNMK)B.O.D.Y ConfidentialIn the latest trading session, shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) moved +1.48%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, ...and more »
05/09/16 02:08 AMGenMark Diagnostics, Inc. (GNMK) Broker Price Targets For The Coming Week - Share Trading News - GenMark Diagnostics, Inc. (GNMK) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of GenMark Diagnostics, Inc. (GNMK). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...FY2016 EPS Estimates for GenMark Diagnostics, Inc Decreased by William Blair (GNMK)Web Breaking Newsall 3 news articles »
05/07/16 06:32 PMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Boasts An Average Rating Of 3 - RealistInvestor.com - GenMark Diagnostics, Inc. (NASDAQ:GNMK) Boasts An Average Rating Of 3RealistInvestor.comAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. GenMark Diagnostics, Inc.
05/06/16 09:28 AMGenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/06/16 01:30 AMGenMark Diagnostics Inc. (GNMK) is Trading Lower on Unusual Volume for May 04 - Equities.com - GenMark Diagnostics Inc. (GNMK) is Trading Lower on Unusual Volume for May 04Equities.comGenMark Diagnostics Inc. (GNMK) experienced unusually high volume on May. 04, as the stock lost 1.23% to a closing price of $5.63. The stock saw 282,829 shares trade hands over the course of the day on 2,088 trades. Given that the stock's average daily ...
05/03/16 08:32 PMEdited Transcript of GNMK earnings conference call or presentation 3-May-16 8:30pm GMT -
05/03/16 03:30 PMGenMark Reports First Quarter 2016 Results - [at noodls] - 598cca98-acdf-42e9-b203-d7ae840a66b2.pdf May 3, 2016 First Quarter Revenue Increased 9% Versus Prior Year to $11.1 million ePlex CE Mark Expected in Second Quarter CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark ...
05/03/16 03:13 PM4:13 pm GenMark Diagnostics reports EPS in-line, beats on revs -
05/03/16 06:07 AMQ1 2016 GenMark Diagnostics Inc Earnings Release - After Market Close -
05/02/16 08:55 PMAverage Analyst Rating for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - B.O.D.Y Confidential - Average Analyst Rating for GenMark Diagnostics, Inc. (NASDAQ:GNMK)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1.5 on GenMark Diagnostics, Inc. (NASDAQ:GNMK) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/02/16 08:55 PMThis Weeks Broker Price Targets For GenMark Diagnostics, Inc. (GNMK) - Share Trading News - This Weeks Broker Price Targets For GenMark Diagnostics, Inc. (GNMK)Share Trading NewsGenMark Diagnostics, Inc. has a 50 day moving average of 5.50 and a 200 day moving average of 6.40. The stock's market capitalization is 252.69M, it has a 52-week low of 4.20 and a 52-week high of 10.84. The share price of the company (GNMK) was ...Genmark Diagnostics Incorporated (NASDAQ:GNMK) Short Interest Decreased By 1.39%The Postall 3 news articles »
04/29/16 07:46 PMGenMark Diagnostics Inc. (GNMK) Drops 6.04% on April 28 - Equities.com - GenMark Diagnostics Inc. (GNMK) Drops 6.04% on April 28Equities.comGenMark Diagnostics Inc. (GNMK) was one of the Russell 2000's biggest losers for Thursday April 28 as the stock slid 6.04% to $6.07, a loss of $-0.39 per share. Starting at an opening price of $6.45 a share, the stock traded between $6.00 and $6.51 ...
04/27/16 02:31 AMGenMark Diagnostics, Inc. (GNMK) Updated Broker Price Targets - Share Trading News - GenMark Diagnostics, Inc. (GNMK) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of GenMark Diagnostics, Inc. (GNMK). The latest reports which are currently in issue on Tuesday 26th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...GenMark Diagnostics, Inc. (NASDAQ:GNMK) Basic Consolidated EPS At $-0.9254Stocks DailyGenmark Diagnostics Incorporated (NASDAQ:GNMK) Shorts Decreased by 2.39% After Short CoveringThe Postall 3 news articles »
04/26/16 07:20 PMGenMark Diagnostics, Inc. (NASDAQ:GNMK) Basic Consolidated EPS At $-0.9254 - Stocks Daily - GenMark Diagnostics, Inc. (NASDAQ:GNMK) Basic Consolidated EPS At $-0.9254Stocks DailyThe basic per-share earnings from continuing operations as confirmed by GenMark Diagnostics, Inc. (NASDAQ:GNMK) for the period closed 2014-12-31 was $-0.9254. For the quarter ended 2014-12-31, this number was $-0.9254. For any specified ...GenMark Diagnostics, Inc. (GNMK) Updated Broker Price TargetsShare Trading NewsGenmark Diagnostics Incorporated (NASDAQ:GNMK) Shorts Decreased by 2.39% After Short CoveringThe Postall 3 news articles »
About GenMark Diagnostics

GenMark Diagnostics logoGenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company. The Company focuses on developing and commercializing its eSensor detection technology. Its eSensor electrochemical technology detects multiple distinct biomarkers in a single sample. It sells its XT-8 instrument and related diagnostic and research tests (XT-8 system) in the United States. It has developed and intends to commercially launch its sample-to-answer ePlex instrument and its associated diagnostic tests, which it collectively refers to as its ePlex system, in Europe and the United States. It operates in the development, manufacturing, sales and support of instruments and molecular tests based on its eSensor detection technology segment. Over four of its diagnostic tests, which run on its XT-8 instrument, have received United States Food and Drug Administration clearance, including Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, Thrombophilia Risk Test and Respiratory Viral Panel.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNMK
  • CUSIP:
Key Metrics:
  • Previous Close: $8.70
  • 50 Day Moving Average: $7.71
  • 200 Day Moving Average: $6.36
  • P/E Ratio: N/A
  • P/E Growth: 5.25
  • Market Cap: $372.26M
  • Current Quarter EPS Consensus Estimate: $-1.23 EPS
Additional Links:
GenMark Diagnostics (NASDAQ:GNMK) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha